We invest in drug discovery, development, and optimization at Aurealcraft Inc., while advancing Pharmacovigilance with ConDrug. Prioritizing drug safety, ConDrug opens our PV Platform Infrastructure to researchers and elevates development-stage insights globally. ConDrug AI, accelerated by NVIDIA GPUs, maps data connections—now available to Growth Plan users.